688399 Stock Overview
A molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Jiangsu Bioperfectus Technologies Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥78.58 |
| 52 Week High | CN¥105.15 |
| 52 Week Low | CN¥49.02 |
| Beta | 0.96 |
| 11 Month Change | 1.26% |
| 3 Month Change | 2.37% |
| 1 Year Change | 41.79% |
| 33 Year Change | -35.05% |
| 5 Year Change | n/a |
| Change since IPO | 43.19% |
Recent News & Updates
Shareholder Returns
| 688399 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -8.4% | -5.6% | -6.7% |
| 1Y | 41.8% | -10.2% | 1.9% |
Return vs Industry: 688399 exceeded the CN Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 688399 exceeded the CN Market which returned 4% over the past year.
Price Volatility
| 688399 volatility | |
|---|---|
| 688399 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 688399 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688399's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 645 | Guoqiang Wang | www.s-sbio.com |
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.
Jiangsu Bioperfectus Technologies Co., Ltd. Fundamentals Summary
| 688399 fundamental statistics | |
|---|---|
| Market cap | CN¥4.46b |
| Earnings (TTM) | -CN¥170.68m |
| Revenue (TTM) | CN¥394.83m |
11.3x
P/S Ratio-26.1x
P/E RatioIs 688399 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688399 income statement (TTM) | |
|---|---|
| Revenue | CN¥394.83m |
| Cost of Revenue | CN¥235.77m |
| Gross Profit | CN¥159.07m |
| Other Expenses | CN¥329.75m |
| Earnings | -CN¥170.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.01 |
| Gross Margin | 40.29% |
| Net Profit Margin | -43.23% |
| Debt/Equity Ratio | 9.5% |
How did 688399 perform over the long term?
See historical performance and comparison